Related references
Note: Only part of the references are listed.Weighted composite time to event endpoints with recurrent events: comparison of three analytical approaches
Ann-Kathrin Ozga et al.
BMC MEDICAL RESEARCH METHODOLOGY (2022)
Clinical milestones in Parkinson's disease: Past, present, and future
Luca Marsili et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2022)
Parkinson's disease clinical milestones and mortality
Maria Camila Gonzalez et al.
NPJ PARKINSONS DISEASE (2022)
Design of a virtual longitudinal observational study in Parkinson's disease (AT-HOME PD)
Ruth B. Schneider et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial
Michael A. Schwarzschild et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Apathy as a behavioural marker of cognitive impairment in Parkinson's disease: a longitudinal analysis
Glen P. Martin et al.
JOURNAL OF NEUROLOGY (2020)
Clinical and Dopamine Transporter Imaging Characteristics of Leucine- Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study
Tanya Simuni et al.
MOVEMENT DISORDERS (2020)
Dysautonomia in early Parkinson disease: a window into the determinants of functional disability and an opportunity for early intervention
Aristide Merola et al.
CLINICAL AUTONOMIC RESEARCH (2020)
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease
Daniel Weintraub et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
David J. Irwin et al.
ANNALS OF NEUROLOGY (2020)
Isradipine Versus Placebo in Early Parkinson Disease A Randomized Trial The Parkinson Study Group STEADY-PD III Investigators
ANNALS OF INTERNAL MEDICINE (2020)
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease
Brit Mollenhauer et al.
MOVEMENT DISORDERS (2019)
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
Tanya Simuni et al.
MOVEMENT DISORDERS (2018)
The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort
Kenneth Marek et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
A User's Guide for α-Synuclein Biomarker Studies in Biological Fluids: Perianalytical Considerations
Brit Mollenhauer et al.
MOVEMENT DISORDERS (2017)
Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease
Eduardo De Pablo-Fernandez et al.
JAMA NEUROLOGY (2017)
Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease
Chelsea Caspell-Garcia et al.
PLOS ONE (2017)
Composite End Points in Clinical Research A Time for Reappraisal
Paul W. Armstrong et al.
CIRCULATION (2017)
Predictors of time to initiation of symptomatic therapy in early Parkinson's disease
Tanya Simuni et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease A Randomized Clinical Trial
Karl Kieburtz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease
Daniel Weintraub et al.
MOVEMENT DISORDERS (2015)
Modelling recurrent events: a tutorial for analysis in epidemiology
Leila D. A. F. Amorim et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)
Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)
Pablo Martinez-Martin et al.
JOURNAL OF NEUROLOGY (2013)
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
Caroline H. Williams-Gray et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale
Glenn T. Stebbins et al.
MOVEMENT DISORDERS (2013)
Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjects
Brit Mollenhauer et al.
NEUROSCIENCE LETTERS (2013)
Age-, gender-, and socioeconomic status-specific incidence of Parkinson's disease and parkinsonism in North East Scotland: The PINE study
Robert Caslake et al.
PARKINSONISM & RELATED DISORDERS (2013)
Design innovations and baseline findings in a long-term Parkinson's trial: The national institute of neurological disorders and stroke exploratory trials in Parkinson's Disease Long-Term Study-1
Jordan J. Elm
MOVEMENT DISORDERS (2012)
Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease
Bernard Ravina et al.
MOVEMENT DISORDERS (2012)
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease
Zhen Hong et al.
BRAIN (2010)
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
Alison T. Stopeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Using Global Statistical Tests in Long-Term Parkinson's Disease Clinical Trials
Peng Huang et al.
MOVEMENT DISORDERS (2009)
Comparative Responsiveness of Parkinson's Disease Scales to Change Over Time
Anette Schrag et al.
MOVEMENT DISORDERS (2009)
Tutorial on methods for interval-censored data and their implementation in R
Guadalupe Gomez et al.
STATISTICAL MODELLING (2009)
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Mariese A. Hely et al.
MOVEMENT DISORDERS (2008)
Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results
Christopher G. Goetz et al.
MOVEMENT DISORDERS (2008)
Clinical diagnostic criteria for dementia associated with Parkinson's disease
Murat Emre et al.
MOVEMENT DISORDERS (2007)
Evolution of cognitive dysfunction in an incident Parkinson's disease cohort
C. H. Williams-Gray et al.
BRAIN (2007)
Prognosis of Parkinson disease - Risk of dementia and mortality: The Rotterdam Study
LML de Lau et al.
ARCHIVES OF NEUROLOGY (2005)
The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study
T Foltynie et al.
BRAIN (2004)
The Unified Parkinson's Disease Rating Scale (UPDRS): Status and recommendations
CG Goetz et al.
MOVEMENT DISORDERS (2003)
Prevalence and characteristics of dementia in Parkinson disease - An 8-year prospective study
D Aarsland et al.
ARCHIVES OF NEUROLOGY (2003)
The association of incident dementia with mortality in PD
G Levy et al.
NEUROLOGY (2002)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
